CDKN2A and cervical cancer: An increased methylation trend of the p16ink4a promoter, from pre-neoplastic to cervical cancer, was found in HPV16+ patients, with a high frequency of E1/E2 disruptions in low-grade squamous intraepithelial cells/high grade squamous intraepithelial cells (LSIL/HSIL) samples.